AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Telemedicine and TDXD: Innovations in Lung Cancer Treatment
This chapter explores the intersection of telemedicine and clinical research in oncology, particularly influenced by the COVID-19 pandemic. It highlights the new approval of TDXD for lung cancer and emphasizes the significance of HER2 testing in treatment strategies. The conversation also addresses the management of side effects and premedication protocols, providing insights into evolving practices among oncologists.